CH619268A5 - - Google Patents

Download PDF

Info

Publication number
CH619268A5
CH619268A5 CH977879A CH977879A CH619268A5 CH 619268 A5 CH619268 A5 CH 619268A5 CH 977879 A CH977879 A CH 977879A CH 977879 A CH977879 A CH 977879A CH 619268 A5 CH619268 A5 CH 619268A5
Authority
CH
Switzerland
Prior art keywords
radical
acid
formula
compounds
ethynyl
Prior art date
Application number
CH977879A
Other languages
German (de)
English (en)
Inventor
Karl Dr Petzoldt
Hans-Joerg Dr Vidic
Klaus Dr Prezewowsky
Yukishige Dr Nishino
Rudolf Prof Dr Wiechert
Henry Dr Laurent
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2449327A external-priority patent/DE2449327C2/de
Priority claimed from DE19752535997 external-priority patent/DE2535997A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH619268A5 publication Critical patent/CH619268A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0059Estrane derivatives substituted in position 17 by a keto group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0081Substituted in position 17 alfa and 17 beta
    • C07J1/0088Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/912Absidia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/913Aspergillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/911Microorganisms using fungi
    • Y10S435/939Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CH977879A 1974-10-14 1979-10-31 CH619268A5 (US20110232667A1-20110929-C00004.png)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2449327A DE2449327C2 (de) 1974-10-14 1974-10-14 7 α-Hydroxy-östradiole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19752535997 DE2535997A1 (de) 1975-08-08 1975-08-08 7-hydroxy-oestradiole

Publications (1)

Publication Number Publication Date
CH619268A5 true CH619268A5 (US20110232667A1-20110929-C00004.png) 1980-09-15

Family

ID=25767825

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1332375A CH619240A5 (US20110232667A1-20110929-C00004.png) 1974-10-14 1975-10-14
CH977879A CH619268A5 (US20110232667A1-20110929-C00004.png) 1974-10-14 1979-10-31

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH1332375A CH619240A5 (US20110232667A1-20110929-C00004.png) 1974-10-14 1975-10-14

Country Status (23)

Country Link
US (1) US4011314A (US20110232667A1-20110929-C00004.png)
JP (1) JPS5165747A (US20110232667A1-20110929-C00004.png)
AT (1) AT348695B (US20110232667A1-20110929-C00004.png)
CA (1) CA1054143A (US20110232667A1-20110929-C00004.png)
CH (2) CH619240A5 (US20110232667A1-20110929-C00004.png)
CS (2) CS205010B2 (US20110232667A1-20110929-C00004.png)
DD (1) DD125588A5 (US20110232667A1-20110929-C00004.png)
DK (1) DK135378C (US20110232667A1-20110929-C00004.png)
ES (1) ES441784A1 (US20110232667A1-20110929-C00004.png)
FI (1) FI54603C (US20110232667A1-20110929-C00004.png)
FR (1) FR2287908A1 (US20110232667A1-20110929-C00004.png)
GB (1) GB1528796A (US20110232667A1-20110929-C00004.png)
HU (1) HU176715B (US20110232667A1-20110929-C00004.png)
IE (1) IE42167B1 (US20110232667A1-20110929-C00004.png)
IL (1) IL48276A (US20110232667A1-20110929-C00004.png)
NL (1) NL7512041A (US20110232667A1-20110929-C00004.png)
NO (1) NO140824C (US20110232667A1-20110929-C00004.png)
NZ (1) NZ178886A (US20110232667A1-20110929-C00004.png)
PH (1) PH13802A (US20110232667A1-20110929-C00004.png)
PL (2) PL103989B1 (US20110232667A1-20110929-C00004.png)
SE (1) SE405254B (US20110232667A1-20110929-C00004.png)
SU (2) SU676170A3 (US20110232667A1-20110929-C00004.png)
YU (2) YU243975A (US20110232667A1-20110929-C00004.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327256D0 (en) * 1983-10-12 1983-11-16 Ici Plc Steroid derivatives
DE3741800A1 (de) * 1987-12-07 1989-06-15 Schering Ag 17-halogenmethylen-estratriene
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
CA2250874A1 (en) 1996-04-09 1997-10-16 Btg International Limited Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
EP1832598A3 (en) 1999-09-30 2008-01-02 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
GB0003524D0 (en) * 2000-02-15 2000-04-05 Btg Int Ltd Cytoprotective steroids (II)
GB2363983A (en) * 2000-06-29 2002-01-16 Hunter Fleming Ltd Protection against neuronal damage using 7-hydroxyepiandrosterone
ATE340580T1 (de) * 2003-05-22 2006-10-15 Pantarhei Bioscience Bv Verwendung von zusammensetzungen enthaltend ein oestrogen zur behandlung und verhinderung von muskelskelettschmerzen
GB0403889D0 (en) * 2004-02-21 2004-03-24 Univ Edinburgh Uses of er-beta modulators
US7910755B2 (en) 2004-09-29 2011-03-22 Harbor Biosciences, Inc. Stem cell expansion and uses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3115444A (en) * 1962-01-22 1963-12-24 Olin Mathieson Process for microbial hydroxylation of steroids containing aromatic alpha-rings

Also Published As

Publication number Publication date
US4011314A (en) 1977-03-08
IL48276A (en) 1979-03-12
NO140824C (no) 1979-11-21
IE42167L (en) 1976-04-14
DK135378C (da) 1977-10-03
SE7511438L (sv) 1976-04-15
PL103989B1 (pl) 1979-07-31
SE405254B (sv) 1978-11-27
DK439975A (da) 1976-04-15
CS205010B2 (en) 1981-04-30
IE42167B1 (en) 1980-06-18
YU294281A (en) 1982-06-30
FR2287908B1 (US20110232667A1-20110929-C00004.png) 1980-04-30
NL7512041A (nl) 1976-04-20
FI752836A (US20110232667A1-20110929-C00004.png) 1976-04-15
FI54603B (fi) 1978-09-29
SU677666A3 (en) 1981-11-30
HU176715B (en) 1981-04-28
AT348695B (de) 1979-02-26
NZ178886A (en) 1978-04-28
IL48276A0 (en) 1975-12-31
PL101461B1 (pl) 1978-12-30
FI54603C (fi) 1979-01-10
FR2287908A1 (fr) 1976-05-14
CS205009B2 (en) 1981-04-30
SU677666A1 (ru) 1981-11-30
CH619240A5 (US20110232667A1-20110929-C00004.png) 1980-09-15
AU8571075A (en) 1977-04-21
YU243975A (en) 1982-06-30
PH13802A (en) 1980-10-01
ATA775475A (de) 1978-07-15
ES441784A1 (es) 1977-04-01
SU676170A3 (ru) 1979-07-25
JPS5165747A (en) 1976-06-07
CA1054143A (en) 1979-05-08
NO753455L (US20110232667A1-20110929-C00004.png) 1976-04-20
GB1528796A (en) 1978-10-18
DK135378B (da) 1977-04-18
DD125588A5 (US20110232667A1-20110929-C00004.png) 1977-05-04
NO140824B (no) 1979-08-13

Similar Documents

Publication Publication Date Title
CH618183A5 (US20110232667A1-20110929-C00004.png)
CH619268A5 (US20110232667A1-20110929-C00004.png)
DE69016627T2 (de) Neue Steroidderivate, die ein substituiertes Ethylradikal an der Stelle 10 des Steroids tragen, Verfahren zu ihrer Herstellung, die Verwendung als Arzneimitte, von einer dieser Verbindungenl und pharmazeutische Präparate von dieser Verbindung.
EP0320437A2 (de) 17-Methylen- und 17-Ethyliden-Estratriene mit östrogener Wirkung
EP0051762B1 (de) 11-Methylen-delta-15-Steroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
CH618704A5 (US20110232667A1-20110929-C00004.png)
DE2546062A1 (de) Delta hoch 15 -steroide
DE1568308B2 (de) Verfahren zur herstellung von delta hoch 4,9,11-trienen der 19-nor- androstanreihe, 17-oxygenierte 3-oxo- 7 alpha-methyl-delta hoch 4,9,11-19 nor- androstatriene und diese enthaltende pharmazeutische praeparate sowie 3-oxo-7 alpha -methyl-delta hoch 5 (10), 9 (11) -19-nor- androstadiene
DE2636405C2 (de) Δ↑1↑↑5↑-17α-Chloräthinyl- und -Propinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
DE2449327A1 (de) 7-hydroxy-oestradiole
DE1904544C3 (de) Verfahren zur mikrobiologischen Umwandlung von 3 ß-Hydroxy-5,6- epoxysteroiden in 6-Hydroxy-3-KetoA<·4 -Steroide
DE2047071C3 (de) pregnadiene, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE2621646A1 (de) 12 alpha-hydroxy-8 alpha-oestradiole
DE2611535A1 (de) 6alpha-hydroxy-8alpha-oestradiole
DE2636404C2 (de) Δ↑1↑↑5↑-17α-Äthinylsteroide der Östranreihe, Verfahren zu ihrer Herstellung sowie diese enthaltende pharmazeutische Präparate
EP0033120B1 (de) 1-Hydroxysteroide, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten
DE2360443A1 (de) D-homo-20-ketopregnane
EP0017094A1 (de) 11-Methylensteroide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2118995A1 (de) Neue oestrogen hochwirksame Steroide und ein Verfahren zu deren Herstellung
DD209636A5 (de) Verfahren zur herstellung von 11beta-chlor-delta-hoch 15-steroiden
DE2636407A1 (de) Delta hoch 15 -steroide
DE2445161A1 (de) D-homo-20-ketopregnane ii
DE2535997A1 (de) 7-hydroxy-oestradiole
AT235476B (de) Verfahren zur Herstellung der neuen 11β,21-Dihydroxy-16α-alkyl-4,17(20)-pregnadien-3-one
DE2450106A1 (de) Neue 1 alpha3-hydroxysteroide

Legal Events

Date Code Title Description
PL Patent ceased